Multiplan Corp
NYSE:MPLN
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
5.21
68
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Multiplan Corp
Multiplan Corp
Cash & Cash Equivalents
Multiplan Corp
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Multiplan Corp
NYSE:MPLN
|
Cash & Cash Equivalents
$71.5m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Veeva Systems Inc
NYSE:VEEV
|
Cash & Cash Equivalents
$1.2B
|
CAGR 3-Years
3%
|
CAGR 5-Years
7%
|
CAGR 10-Years
24%
|
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Cash & Cash Equivalents
$147.5m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
|
Doximity Inc
NYSE:DOCS
|
Cash & Cash Equivalents
$96.8m
|
CAGR 3-Years
13%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
|
Omnicell Inc
NASDAQ:OMCL
|
Cash & Cash Equivalents
$570.6m
|
CAGR 3-Years
6%
|
CAGR 5-Years
33%
|
CAGR 10-Years
19%
|
|
|
W
|
Waystar Holding Corp
NASDAQ:WAY
|
Cash & Cash Equivalents
$35.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Multiplan Corp
Glance View
MultiPlan Corp. provides healthcare cost management solutions. The company is headquartered in New York City, New York and currently employs 2,400 full-time employees. The company went IPO on 2020-02-10. The firm's services include analytics-based services, which uses information technology platform to offer customers analytics-based services to detect claims over-charges and recommend or negotiate fair reimbursement. Its Network-Based Services includes multiplan's primary and complementary networks in which payors can utilize its national network of contracted providers to process claims at a discount. Its payment integrity services use data, technology, and clinical expertise to identify improper, unnecessary and excessive charges before or after claims are paid. Its revenue integrity services use data, technology, and clinical expertise to improve accuracy of premiums paid to medicare advantage plans by Centers for Medicare and Medicaid Services (CMS).
See Also
What is Multiplan Corp's Cash & Cash Equivalents?
Cash & Cash Equivalents
71.5m
USD
Based on the financial report for Dec 31, 2023, Multiplan Corp's Cash & Cash Equivalents amounts to 71.5m USD.
What is Multiplan Corp's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 3Y
-17%
Over the last year, the Cash & Cash Equivalents growth was -79%. The average annual Cash & Cash Equivalents growth rates for Multiplan Corp have been -17% over the past three years .
You don't have any saved screeners yet
